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Abstract
Histopathological studies have demonstrated the involvement of spinal cord grey matter (GM) and white matter (WM) in
several diseases and recent research has suggested the use of magnetic resonance imaging (MRI) as a promising tool for in
vivo assessment of the upper spinal cord. However, many neurological conditions would benefit from quantitative
assessment of tissue integrity at different levels and relatively little work has been done, mainly due to technical challenges
associated with imaging the lower spinal cord. In this study, the value of the lumbosacral enlargement (LSE) as an intrinsic
imaging biomarker was determined by exploring the feasibility of obtaining within it reliable GM and WM cross-sectional
area (CSA) measurements by means of a commercially available MRI system at 3 tesla (T). 10 healthy volunteers (mean age
27.5 years, 6 female) gave written informed consent and high resolution images of the LSE were acquired and analysed
using an optimised MRI acquisition and analysis protocol. GM and WM mean CSA measurements were obtained from a
15 mm section at the level of the LSE and the reproducibility of the measurements was determined by means of scan-
rescan, intra- and inter-observer assessments. Mean (6SD) LSE cross-sectional area (LSE-CSA) was 62.3 (64.1) mm2 and
mean (6SD) LSE grey matter cross-sectional area (LSE-GM-CSA) was 19.8 (63.3) mm2. The mean scan-rescan, intra- and
inter-observer % coefficient of variation (COV) for measuring the LSE-CSA were 2%, 2% and 2.5%, respectively and for
measuring the LSE-GM-CSA were 7.8%, 8% and 8.6%, respectively. This study has shown that the LSE can be used reliably as
an intrinsic imaging biomarker. The method presented here can be potentially extended to study the LSE in the diseased
state and could provide a solid foundation for subsequent multi-parametric MRI investigations.
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Introduction
Many neurological conditions cause intrinsic pathological
changes in the spinal cord (SC) [1]. Some conditions like
Friedrich’s ataxia (FRDA) and leucodystrophies will only affect
the white matter (WM) tracts of the SC [2,3] while others, such as
amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), will
involve both the grey matter (GM) and WM [4–7]. The variety
and discriminating behaviour of intrinsic SC pathologies has
profound clinical implications; purely GM lesions (sparing
surrounding WM) cause clinical dysfunctions that correspond to
the level of the pathological changes, while WM tract destruction
will lead to motor, sensory and sphincter symptoms below the level
of the damage [8].
Previous research has used cross-sectional area (CSA) measure-
ments of the upper cervical cord, obtained by means of magnetic
resonance imaging (MRI), to assess the degree of atrophy (i.e.
tissue loss, which implies neurodegeneration). This measure has
been significantly correlated with measures of locomotor disability
in people with MS [9–11], while a decline of spinal cord CSA over
time of between 11% and 30% has also been observed in cases of
chronic spinal cord injury (SCI) using similar methodologies [12–
14]. While measuring atrophy and cross-sectional dimensions
provides an index of overall damage to the cord over time, it does
not elucidate between individual rates of tissue (WM and GM) loss,
which may have prognostic implications with respect to both
disease progression rates and response to treatment. The use of
MRI to assess tissue-specific changes within the SC has been
limited due to a number of technical factors relating to resolution,
signal-to-noise ratio (SNR) and motion artefacts, which make it
technically difficult to assess the integrity of the SC in detail [15].
Recent research has shown the potential to segment GM and
WM reliably within the healthy cervical spinal cord [16] but
evidence from ex vivo investigations has shown that loss of somatic
and motor neurons may also occur in the lower spinal cord and
maybe best studied independently when trying to address clinical
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questions [17]. The need to develop new imaging methods to
gauge tissue-specific changes in the lumbar region is therefore
profound, as it would allow important neurological conditions
such as the aforementioned to be studied in detail. However, the
study of the lumbar SC poses additional challenges which merit
investigation in their own right. For example, the cord segments in
the lumbar SC do not correspond consistently with the vertebral
body levels [18,19] and these positional variations of the SC must
be accounted for. In addition, technical considerations such as the
management of patient related and physiological motion, or
identifying the correct balance between image resolution, SNR
and scan time, are all equally important determinants of a
clinically useful imaging protocol.
In this study, a commercially available MR sequence and image
analysis software are utilised in a protocol for GM and WM
segmentation in the lumbar SC, which takes into account the
technical challenges associated with imaging the lumbar SC. One
of the innovative strategies employed in this study is to take into
account the positional variations of the SC through the use of the
lumbosacral enlargement (LSE) as an intrinsic imaging biomarker,
owing to its consistent relationship with the T11 - L1 lumbar SC
segments [20]. Positional variations in the lower SC have been
studied previously in the context of providing important safety
information in spinal anaesthesia for preventing intrathecal
needles from being directed close to the cord, mainly by reporting
the termination level of the conus medullaris [21–23]. The conus
medullaris extends caudally from the LSE and becomes gradually
narrower and thinner. The LSE is a large enough structure that
can be studied reliably with clinically available MR systems. This
work assesses the reproducibility of the proposed MR imaging and
analysis protocol and provides normative data hitherto unreported
in vivo, serving as a foundation for further multi-parametric MR
investigations in the lumbar SC.
Materials and Methods
Study participants
Ten healthy adult volunteers were recruited for the study (mean
age 27.5 years, 6 female, range 21–35). Written informed consent
was obtained from all participants and the work was approved by
the National Hospital for Neurology and Neurosurgery and the
Institute of Neurology Joint Research and NRES Committee
London Bloomsbury (Formally London REC 2 Ethics Commit-
tee).
MR imaging
A 3T Philips Achieva MRI system was used with dual-transmit
technology (Philips Healthcare, Best, Netherlands) using the
manufacturer’s 16-channel neurovascular (NV) coil and 15-
channel SENSE spine coil. Considering previously reported
imaging protocols that offered high image contrast in the upper
spinal cord [16,24], the lumbar SC was imaged in the axial
plane with the slices perpendicular to the cord using a fat-
suppressed 3D slab-selective fast field echo (FFE) sequence and the
following acquisition parameters (for acquisition parameter
optimisation details refer to Appendix S1): Repetition time
(TR) = 23 ms; echo time (TE) = 4.4 ms, flip angle a=10u, field
of view (FOV) = 1806180 mm2, voxel size = 0.560.565 mm3,
number of averages (NEX) = 8, 19 axial contiguous slices and
scanning time of 19:27 min. The first slice of the imaging volume
was positioned at the superior margin of the T11 vertebral body
with the volume extending minimally to the inferior margin of the
L1 vertebral body to ensure coverage of the LSE in all subjects
(see Figure 1).
Motion artefacts were reduced by using velcro straps to restrain
the torso and through the use of foam padding to reduce
inadvertent movements of the upper neck. Hip flexion was
achieved through the use of a large foam wedge that increased the
level of contact between the lower back and the coil surface. Every
effort was made to ensure the participants were as comfortable as
possible in the scanner.
Image analysis
Image analysis was performed using JIM 6.0 (Xinapse systems,
http://www.xinapse.com). A 15 mm section of the cord (i.e. 3
slices) was extracted and segmented based on previously described
methodologies in the cervical spine [11,16] as follows: Using the
active surface model (ASM) segmentation method, seed points
were manually positioned in the centre of the cord on all axial
slices between T11-L1 and CSA measurements were obtained (see
Figure 2a and 2b). In each subject, the slice with the largest CSA
between T11-L1 was identified and the two adjacent slices were
subsequently included in further analysis. GM segmentation was
done based on a previously reported method [16], predominantly
with the use of the fuzzy connector segmentation [25] available in
Jim 6.0, but with manual editing whenever necessary to obtain the
final GM contour (see Figure 2c and Figure S3). The CSA of WM
(LSE-WM-CSA) was recorded as the difference between LSE-
CSA and LSE-GM-CSA.
Reproducibility assessment
Five out of ten study participants had three repeated scans, each
performed on different occasions (at least one week apart), in order
to test for ‘scan-rescan’ reproducibility; reproducibility was
assessed by one experienced rater analysing all the data. In order
to demonstrate intra-observer reproducibility, the same rater re-
analysed all the data from the 5 volunteers’ first visit 3 times; the
analysis was done on separate occasions with a minimum of 2
weeks between each analysis. Inter-observer reproducibility was
assessed by employing a second and third rater to analyse the data
from the 5 volunteers’ first visit.
Additional measures such us the Dice similarity coefficient
(DSC) [26] and the modified Housdorff distance (MHD) [27] were
also obtained. The DSC is a measurement of spatial overlap
Figure 1. Imaging the lumbosacral enlargement (LSE). The
imaging volume was prescribed to cover from the superior margin of
T11 to the inferior margin of the L1 vertebral bodies so that to ensure
coverage of the LSE in all subjects. Example images are shown from
superior, middle and inferior sections of the imaging volume.
doi:10.1371/journal.pone.0105544.g001
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between two sets and represents the size of the union of two sets
divided by the average size of the two sets; a value of 0 indicates no
overlap while a value of 1 indicates perfect agreement. The MHD
between two sets represents a measure of the distance between
points in one set to the corresponding nearest points in the other
set; lower MHD units (MHDu) indicate better registration.
Statistics
Statistical analysis was performed using SPSS 11.0 (SPSS,
Chicago, Ill., USA). For the assessment of intra- and inter-observer
reproducibility as well as scan-rescan reproducibility, the coeffi-
cient of variation (COV) was calculated using the mean and
standard deviation from the repeated measures and the equation
COV= [SD/mean] 6100%. In order to estimate the measure-
ment error relative to the biological variability between subjects,
the intra-class correlation coefficient (ICC) was calculated.
Results
All the acquired images were included in the analysis and no
data had to be discarded because of motion or other artefacts. The
segmentation of the LSE-CSA was successfully performed using
the ASM method without the need for manual intervention.
However, the segmentation of the LSE-GM-CSA required
manual editing in all cases. Mean (6SD) LSE-CSA of the
15 mm section studied (i.e. 3 slices) across 10 healthy subjects was
62.3 (64.1) mm2 and mean (6SD) LSE-GM-CSA was 19.8 (63.3)
mm2. Figure 3 shows a stacked plot diagram of the mean GM and
WM area fractions measured within the LSE in the 10 healthy
subjects that took part in the study.
The mean scan-rescan, intra- and inter-observer % COV for
measuring the LSE-CSA were 2%, 2% and 2.5%, respectively.
The mean scan-rescan, intra- and inter-observer % coefficient of
variation for measuring the LSE-GM-CSA were 7.8%, 8% and
8.6%, respectively. The ICC for LSE-CSA measurements was
0.76 and for LSE-GM-CSA measurements was 0.87.
Mean (6SD) DSC of the LSE-CSA (0.9760.01) and the LSE-
GM-CSA (0.8960.01) for a single rater (intra-observer) in 5
healthy subjects and the mean DSC of the LSE-CSA (0.9760.01)
and the LSE-GM-CSA (0.8860.01) for 3 raters (inter-observer)
are shown in Figure 4a. Figure 4b shows the intra-observer MHD
of the LSE-CSA (0.1760.07) and the LSE-GM-CSA (0.2160.07)
and the inter-observer MHD of the LSE-CSA (0.1660.02) and the
LSE-GM-CSA (0.2360.04). More details regarding the measure-
ments of each observer and the corresponding similarity
measurements can be found in Table S1, Table S2, Table S3,
and Table S4.
Discussion
In this study we have successfully presented a clinically feasible
MRI protocol for obtaining tissue-specific (i.e. GM and WM) CSA
measurements in the lumbar SC in healthy subjects using
commercially available hardware and software, which has the
potential for immediate clinical utility. The motivation for
pursuing this study was found in the fact that cervical SC atrophy
observed by measuring changes in CSA cross-sectionally and over
time has provided valuable insights into disease state and evolution
in MS and other important neurological conditions [9–14]. To
date there are no clinical studies reporting such changes at lumbar
level and there is little doubt that the development of imaging
Figure 2. Segmentation of the lumbosacral enlargement (LSE) using the active surface model (ASM) method. a) seed points are first
positioned within the cord and b) the boundary of the cord is identified to obtain cross-sectional area (CSA) measurements of the LSE c) the grey
matter (GM) boundary and CSA is also obtained using semi-automated and manual editing techniques.
doi:10.1371/journal.pone.0105544.g002
Figure 3. Stacked plot diagram showing grey matter (GM) and
white matter (WM) mean area fractions measured in a 15 mm
section through the lumbosacral enlargement (LSE) in 10
healthy subjects.
doi:10.1371/journal.pone.0105544.g003
Figure 4. Image segmentation assessment. a) mean Dice similarity
coefficient (DSC) of the lumbosacral enlargement (LSE) cross-sectional
area (LSE-CSA) and the LSE grey matter cross-sectional area (LSE-GM-
CSA) in 5 healthy subjects obtained from a single rater (intra-observer)
and 3 raters (inter-observer) b) mean modified Housdorff distance
(MHD) of the LSE-CSA and the LSE-GM-CSA.
doi:10.1371/journal.pone.0105544.g004
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methods to study the lower SC will provide invaluable information
to better understand the pathophysiology of commonly reported
symptoms relevant to this level of the SC such as bladder and
sexual dysfunction for example, which is a major problem not only
in MS [28,29] but in conditions like spinal cord injury (SCI) [30–
36] and multiple system atrophy (MSA)[37,38]. In MS, bladder
symptoms are often attributed to spinal cord lesions, although in
some cases no obvious lesions are present to account for bladder
problems, raising the possibility that axonal degeneration may also
be occurring in pathways that affect the bladder [28]. It is also
evident that bladder problems in SCI may exist even in patients
with relatively preserved neurological function [30] and medical
imaging has offered very little so far in our understanding of these
symptoms.
A number of hurdles unique to lumbar SC imaging had to be
overcome to achieve these results. Firstly, the anatomical
curvature and variation in this segment of the SC meant that a
reproducible localisation strategy had to be implemented that was
dependant on intrinsic SC markers. The LSE had been shown to
be always located between the T11-L1 vertebral bodies [20] and
as such, coverage of this section was deemed to be a pre-requisite
in the final imaging protocol. The localisation technique further
relied on identifying the widest section of the LSE, which is its
mid-point, and in doing so reliably captured the lumbar segments
of the SC. A minor drawback of this method, albeit unavoidable,
was the requirement of using a sufficiently high number of slices to
ensure coverage of the T11-L1 section with a consequent increase
in the total scan time.
The optimisation of the 3D-FFE sequence parameters to
achieve high image contrast involved the use of a low flip angle
(a=10u, for reduced T1 weighting) and short TR and TE (22 ms
and 4.4 ms, respectively) for the acquisition of mixed proton
density and T2* weighted images that have been shown to offer
optimum contrast between the tissue types in previous studies of
the cervical SC [16]. The voxel dimensions of 0.5 mm60.5 mm in
plane with a slice thickness of 5 mm was chosen to ensure reduced
in-plane partial volume effects whereas the slice thickness was
appropriate due to less variation in the longitudinal SC axis. In
addition, SNR limitations due to the coil design and scan time
restrictions meant it was not possible to consider acquisitions with
reduced slice thickness. With dedicated coils it may be possible to
increase SNR and improve through-plane resolution by reducing
slice thickness. This would reduce the partial volume effect, which
can affect the sharpness of the GM/WM boundary. Of course,
SNR gain from dedicated coils may also be utilised in order to
reduce the acquisition time and to make this protocol more
acceptable in the clinical setting. In this particular protocol, a high
number of averages was acquired (NEX=8) in order to boost
SNR. We investigated the option of magnitude averaging by
acquiring 8 separate images to register and average in image-
space, but the low SNR of each acquisition impaired the
registration process, therefore k-space averaging was deemed
appropriate.
Subject immobilization was absolutely essential to avoid
movement artefacts and this was achieved by applying velcro
straps across the torso and through the use of a standard MRI
compatible cervical collar. Optimal positioning was achieved with
the subjects lying flat with their knees bent at a 120 degree angle in
the hip flexed position for improved contact of the lower back with
the surface coil.
The reproducibility results demonstrated a mean scan-rescan,
intra- and inter-observer % coefficient of variation for measuring
the LSE-CSA of 2%, 2% and 2.5%, respectively and for
measuring the LSE-GM-CSA; 7.8%, 8% and 8.6%, respectively.
While there are no identical studies in the literature with which to
directly compare these figures, these results are encouraging
nevertheless as they are comparable to those obtained in the
cervical SC, opening up the possibility to implement the method in
the clinical setting using commercially available hardware.
Horsfield et al. [11] demonstrated intra- and inter-observer COVs
of 0.59% and 1.36%, respectively in cervical SC CSA measure-
ments while Yiannakas et al. [16] have shown cervical SC CSA
intra- and inter-observer COVs of 0.5% and 0.5%, respectively. In
the original study by Losseff et al. [10], the mean scan-rescan
COV was 0.8% in the cervical SC. The results of the present pilot
study are promising and are in keeping with the results seen in the
upper cervical cord CSA, although the small differences observed
may be due to several factors, ranging from coil design differences
and image resolution differences to the diameter of the cord itself,
which has been shown from this study to be smaller in the lumbar
SC than in the cervical SC, measured using similar methodologies
[16].
With respect to GM COVs, the current work yielded values of
7.8%, 8% and 8.6%, respectively, which are different to previously
reported values of 6.5%, 5.4% and 12.7% in the upper cervical SC
[16]. The differences in COVs may be attributable to one, or a
combination of factors such as partial volume effects which have a
greater influence in GM estimation due to the tissue’s smaller
CSA; or the subjective GM segmentation that relied upon
operator judgement rather than an automated process. At present
there is no agreement on an established method for reliable
segmentation of SC GM. The fuzzy connector method is a good
starting point but manual editing was required in all cases.
Although automated GM segmentation software could assist in
improving the consistency of analysis, there would still be errors
due to partial volume effects, which cannot exclude the need for
manual outlining and correction of the masks.
In summary, this study has presented a new MRI acquisition
and analysis protocol that uses the LSE as an intrinsic imaging
biomarker, opening up the possibility of assessing neurological
conditions that may differentially affect GM and WM in the lower
SC. The protocol was developed on a clinical 3T system and is
ready for immediate translation to further in vivo human studies.
Further development will be focused on multi-modal quantitative
MRI analysis and also on developing lumbar SC templates for
registration purposes in view of possible group analysis.
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Appendix S1 Acquisition parameter optimisation.
(DOCX)
Dataset S1 Details of all measurements obtained in the
reproducibility study.
(XLSX)
Figure S1 Imaging protocol optimisation and contrast-
to-noise ratio (CNR) measurements. a) plot demonstrating
the effect of varying the echo time (TE) on grey matter (GM)/
white matter (WM), by keeping the repetition time (TR) and flip
angle constant, and the corresponding images at b) TE= 4.4 ms,
CNR=5.8 c) TE= 15 ms, CNR=4.3 d) TE= 26 ms,
CNR=3.1 e) TE=37 ms, CNR=0.5.
(TIFF)
Figure S2 Contrast-to-noise (CNR) calculation method.
a) example of region of interest (ROI) placement within white
matter (WM) and grey matter (GM) on the original image b)
interpolated image for better visualisation.
(TIFF)
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Figure S3 Image segmentation example of the lumbo-
sacral enlargement grey matter cross-sectional area
(LSE-GM-CSA) in two healthy subjects (a-b). Top figures
show the magnified original image, middle figures show the
unedited LSE-GM-CSA contours (in white) and bottom figures
show how these have been edited manually (final contours are
shown in red).
(TIFF)
Table S1 Inter-observer lumbosacral enlargement
cross-sectional area (LSE-CSA) measurements (mm2).
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Table S2 Inter-observer lumbosacral enlargement grey
matter cross-sectional area (LSE-GM-CSA) measure-
ments (mm2).
(DOCX)
Table S3 Mean inter-observer similarity measure-
ments of the lumbosacral enlargement cross-sectional
area (LSE-CSA).
(DOCX)
Table S4 Mean inter-observer similarity measure-
ments of the lumbosacral enlargement grey matter
cross-sectional area (LSE-GM-CSA).
(DOCX)
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